Effects of Mifepristone on Biomarkers of Metabolic Function and Neuropsychological Performance Among Middle-Aged and Older Individuals
Phase of Trial: Phase II
Latest Information Update: 27 Jan 2018
Price : $35 *
At a glance
- Drugs Mifepristone (Primary)
- Indications Depression
- Focus Biomarker; Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 03 Oct 2017 Status changed from recruiting to completed.
- 19 Apr 2016 Planned End Date changed from 1 Feb 2016 to 1 Feb 2017.